+关注
Pharmyang
药物研发专业,对美国医药股感兴趣
IP属地:海外
63
关注
233
粉丝
3
主题
0
勋章
主贴
热门
Pharmyang
2022-01-19
$Rivian Automotive, Inc.(RIVN)$
上周买了82的put,1.21到期,希望它继续跌,弥补我在 $Tesla$ call 上的损失
Pharmyang
2022-01-19
$特斯拉(TSLA)$
做个实验,看看自己能不能发帖?手机端总是显示中国人要实名认证,课我在海外没有国内手机
Pharmyang
2021-05-05
$Atea Pharmaceuticals, Inc.(AVIR)$
Merck宣布免费授权给印度它的抗病毒药,对ATEA是一大利空。另外,好像流通股变多了很多。
Pharmyang
2021-01-05
2020 美股疫苗股交易总结
2020年无疑是整个人类社会的一个大灾难,但因为疫情造成的股市震荡真是一个千载难逢的挣钱机会,如果抓住机会,是可以大挣一笔的。可惜本人水平有限,没能挣到太多,但确实也学到了很多心得,一些血的教训,希望对自己将来的投资有帮助。本文总结自己2020年疫苗股的交易过程。
$NanoViricides Inc.(NNVC)$
: 疫情在武汉一月份爆发,美股马上跟风,相关概念股水涨船高。首先进入视线的是一只垃圾股,NNVC,几个印度人搞的一个空壳公司,靠蹭热点,一个概念炒了N多年,实际上药物研发没有任何进展。因为CEO在采访时大放厥词,他们的产品有可能对病毒有效,股价直接暴涨。在研究明白这家公司的本质后,果断做空,8.5 和9.5元两处卖空股票,坚信这只垃圾股早晚会跌回5元以下(备注2020.12.31 收盘价2.87)。可是美股太疯狂了,风口来了,猪都会飞,这只垃圾股最高窜到19.2,弄得我心惊胆战。最后在8 和7.5 位置平了空仓,小获利了结。心得:虽然坚信长期方向,但做空压力太大,心态不够坚定,拿不住。
$Moderna, Inc.(MRNA)$
:2019年因为工作原因就了解了mRNA疫苗,非常看好mRNA疫苗的方向,ModernRNA和BioNTech公司一直在我观察列表里,可惜没有入手买。2020.6MRNA临床一期结果出来后,股价暴涨到87 后慢慢下跌,根据我对他们技术和数据的分析,认为后续2/3期希望很大,于是在6月份回调后60左右建仓。很快,7月底受临床2期好结果刺激,又一**涨。这时候我的心态问题又犯病了,第一天暴涨到80后,心
2020 美股疫苗股交易总结
Pharmyang
2019-10-11
$Sangamo BioSciences(SGMO)$
这货最近持续下跌,投资人不看好
Pharmyang
2019-01-29
$Sangamo BioSciences(SGMO)$估计二月份的报告会出些好结果,估计能涨涨
Pharmyang
2018-07-17
$CRISPR Therapeutics AG(CRSP)$ crispr遭遇巨大挑战,短期内看空
Pharmyang
2018-06-29
最近老虎行情刷新特别慢,个股新闻推送还停留在五月份。是我系统的问题吗?大家最近体验如何?
Pharmyang
2018-04-10
分析的好
@科迪勒拉:CNAT: 道阻且长 行则将至
Pharmyang
2018-02-17
$Eyenovia Inc.(EYEN)$这股成交量可真惨淡
Pharmyang
2017-11-28
这股最近强势反弹,看来有翻身的机会了
$Northwest Biotherapeutics(NWBO)$这股最近强势反弹,看来有翻身的机会了
这股最近强势反弹,看来有翻身的机会了
Pharmyang
2017-09-29
看好产品线,应该会涨起来
$Deciphera Pharmaceuticals Inc.(DCPH)$新股发行第一帖,果断入手1000股,早晚能涨起来
看好产品线,应该会涨起来
Pharmyang
2017-08-23
有收购传闻,要上吗?
$Paratek Pharmaceuticals Inc.(PRTK)$盘前暴涨
有收购传闻,要上吗?
Pharmyang
2017-07-29
$德纳维制药(DVAX)$乙肝疫苗终于被认可了,投票11:1 推荐,果断买入,15.7-16.0入手,下周开盘还会继续大涨
Pharmyang
2017-07-27
$Intellipharmaceutics Internation(IPCI)$FDA拒了
Pharmyang
2017-07-21
$Kala Pharmaceuticals Inc.(KALA)$继续打新股, 好的公司打新还是相当安全的
Pharmyang
2017-07-14
$Portola Pharmaceuticals Inc.(PTLA)$这股自从拿到批件暴涨后还在慢慢涨,长期看好啊
Pharmyang
2017-07-08
$Pieris Pharmaceuticals, Inc.(PIRS)$ 趋势不错,长期看好
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3461771638976755","uuid":"3461771638976755","gmtCreate":1498677681581,"gmtModify":1498753032512,"name":"Pharmyang","pinyin":"pharmyang","introduction":"","introductionEn":null,"signature":"药物研发专业,对美国医药股感兴趣","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":233,"headSize":63,"tweetSize":18,"questionSize":0,"limitLevel":900,"accountStatus":3,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":3,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":64,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"海外","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":697545586,"gmtCreate":1642543473616,"gmtModify":1642543473616,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RIVN\">$Rivian Automotive, Inc.(RIVN)$</a>上周买了82的put,1.21到期,希望它继续跌,弥补我在 $Tesla$ call 上的损失","listText":"<a href=\"https://laohu8.com/S/RIVN\">$Rivian Automotive, Inc.(RIVN)$</a>上周买了82的put,1.21到期,希望它继续跌,弥补我在 $Tesla$ call 上的损失","text":"$Rivian Automotive, Inc.(RIVN)$上周买了82的put,1.21到期,希望它继续跌,弥补我在 $Tesla$ call 上的损失","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":72,"commentSize":12,"repostSize":1,"link":"https://laohu8.com/post/697545586","isVote":1,"tweetType":1,"viewCount":1726,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697545111,"gmtCreate":1642543262290,"gmtModify":1642598804002,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a>做个实验,看看自己能不能发帖?手机端总是显示中国人要实名认证,课我在海外没有国内手机","listText":"<a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a>做个实验,看看自己能不能发帖?手机端总是显示中国人要实名认证,课我在海外没有国内手机","text":"$特斯拉(TSLA)$做个实验,看看自己能不能发帖?手机端总是显示中国人要实名认证,课我在海外没有国内手机","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":217,"commentSize":49,"repostSize":28,"link":"https://laohu8.com/post/697545111","isVote":1,"tweetType":1,"viewCount":9910,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"275819275022896","authorId":"275819275022896","name":"约翰","avatar":"https://static.tigerbbs.com/ad1bbc78ee49142cbe14dec72f0436a6","crmLevel":1,"crmLevelSwitch":0,"idStr":"275819275022896","authorIdStr":"275819275022896"},"content":"我带着中国的华为和中国电信芯片和号码,在加拿大用苹果手机下载老虎证券app, 登陆时用中国号码,密码自己设定,第一次好像要验证码。","text":"我带着中国的华为和中国电信芯片和号码,在加拿大用苹果手机下载老虎证券app, 登陆时用中国号码,密码自己设定,第一次好像要验证码。","html":"我带着中国的华为和中国电信芯片和号码,在加拿大用苹果手机下载老虎证券app, 登陆时用中国号码,密码自己设定,第一次好像要验证码。"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":106745387,"gmtCreate":1620156884249,"gmtModify":1620156884249,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AVIR\">$Atea Pharmaceuticals, Inc.(AVIR)$</a>Merck宣布免费授权给印度它的抗病毒药,对ATEA是一大利空。另外,好像流通股变多了很多。","listText":"<a href=\"https://laohu8.com/S/AVIR\">$Atea Pharmaceuticals, Inc.(AVIR)$</a>Merck宣布免费授权给印度它的抗病毒药,对ATEA是一大利空。另外,好像流通股变多了很多。","text":"$Atea Pharmaceuticals, Inc.(AVIR)$Merck宣布免费授权给印度它的抗病毒药,对ATEA是一大利空。另外,好像流通股变多了很多。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/106745387","isVote":1,"tweetType":1,"viewCount":2696,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":338904251,"gmtCreate":1609797702373,"gmtModify":1715012530169,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"title":"2020 美股疫苗股交易总结","htmlText":"2020年无疑是整个人类社会的一个大灾难,但因为疫情造成的股市震荡真是一个千载难逢的挣钱机会,如果抓住机会,是可以大挣一笔的。可惜本人水平有限,没能挣到太多,但确实也学到了很多心得,一些血的教训,希望对自己将来的投资有帮助。本文总结自己2020年疫苗股的交易过程。<a target=\"_blank\" href=\"https://laohu8.com/S/NNVC\">$NanoViricides Inc.(NNVC)$</a> : 疫情在武汉一月份爆发,美股马上跟风,相关概念股水涨船高。首先进入视线的是一只垃圾股,NNVC,几个印度人搞的一个空壳公司,靠蹭热点,一个概念炒了N多年,实际上药物研发没有任何进展。因为CEO在采访时大放厥词,他们的产品有可能对病毒有效,股价直接暴涨。在研究明白这家公司的本质后,果断做空,8.5 和9.5元两处卖空股票,坚信这只垃圾股早晚会跌回5元以下(备注2020.12.31 收盘价2.87)。可是美股太疯狂了,风口来了,猪都会飞,这只垃圾股最高窜到19.2,弄得我心惊胆战。最后在8 和7.5 位置平了空仓,小获利了结。心得:虽然坚信长期方向,但做空压力太大,心态不够坚定,拿不住。<a target=\"_blank\" href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a> :2019年因为工作原因就了解了mRNA疫苗,非常看好mRNA疫苗的方向,ModernRNA和BioNTech公司一直在我观察列表里,可惜没有入手买。2020.6MRNA临床一期结果出来后,股价暴涨到87 后慢慢下跌,根据我对他们技术和数据的分析,认为后续2/3期希望很大,于是在6月份回调后60左右建仓。很快,7月底受临床2期好结果刺激,又一**涨。这时候我的心态问题又犯病了,第一天暴涨到80后,心","listText":"2020年无疑是整个人类社会的一个大灾难,但因为疫情造成的股市震荡真是一个千载难逢的挣钱机会,如果抓住机会,是可以大挣一笔的。可惜本人水平有限,没能挣到太多,但确实也学到了很多心得,一些血的教训,希望对自己将来的投资有帮助。本文总结自己2020年疫苗股的交易过程。<a target=\"_blank\" href=\"https://laohu8.com/S/NNVC\">$NanoViricides Inc.(NNVC)$</a> : 疫情在武汉一月份爆发,美股马上跟风,相关概念股水涨船高。首先进入视线的是一只垃圾股,NNVC,几个印度人搞的一个空壳公司,靠蹭热点,一个概念炒了N多年,实际上药物研发没有任何进展。因为CEO在采访时大放厥词,他们的产品有可能对病毒有效,股价直接暴涨。在研究明白这家公司的本质后,果断做空,8.5 和9.5元两处卖空股票,坚信这只垃圾股早晚会跌回5元以下(备注2020.12.31 收盘价2.87)。可是美股太疯狂了,风口来了,猪都会飞,这只垃圾股最高窜到19.2,弄得我心惊胆战。最后在8 和7.5 位置平了空仓,小获利了结。心得:虽然坚信长期方向,但做空压力太大,心态不够坚定,拿不住。<a target=\"_blank\" href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a> :2019年因为工作原因就了解了mRNA疫苗,非常看好mRNA疫苗的方向,ModernRNA和BioNTech公司一直在我观察列表里,可惜没有入手买。2020.6MRNA临床一期结果出来后,股价暴涨到87 后慢慢下跌,根据我对他们技术和数据的分析,认为后续2/3期希望很大,于是在6月份回调后60左右建仓。很快,7月底受临床2期好结果刺激,又一**涨。这时候我的心态问题又犯病了,第一天暴涨到80后,心","text":"2020年无疑是整个人类社会的一个大灾难,但因为疫情造成的股市震荡真是一个千载难逢的挣钱机会,如果抓住机会,是可以大挣一笔的。可惜本人水平有限,没能挣到太多,但确实也学到了很多心得,一些血的教训,希望对自己将来的投资有帮助。本文总结自己2020年疫苗股的交易过程。$NanoViricides Inc.(NNVC)$ : 疫情在武汉一月份爆发,美股马上跟风,相关概念股水涨船高。首先进入视线的是一只垃圾股,NNVC,几个印度人搞的一个空壳公司,靠蹭热点,一个概念炒了N多年,实际上药物研发没有任何进展。因为CEO在采访时大放厥词,他们的产品有可能对病毒有效,股价直接暴涨。在研究明白这家公司的本质后,果断做空,8.5 和9.5元两处卖空股票,坚信这只垃圾股早晚会跌回5元以下(备注2020.12.31 收盘价2.87)。可是美股太疯狂了,风口来了,猪都会飞,这只垃圾股最高窜到19.2,弄得我心惊胆战。最后在8 和7.5 位置平了空仓,小获利了结。心得:虽然坚信长期方向,但做空压力太大,心态不够坚定,拿不住。$Moderna, Inc.(MRNA)$ :2019年因为工作原因就了解了mRNA疫苗,非常看好mRNA疫苗的方向,ModernRNA和BioNTech公司一直在我观察列表里,可惜没有入手买。2020.6MRNA临床一期结果出来后,股价暴涨到87 后慢慢下跌,根据我对他们技术和数据的分析,认为后续2/3期希望很大,于是在6月份回调后60左右建仓。很快,7月底受临床2期好结果刺激,又一**涨。这时候我的心态问题又犯病了,第一天暴涨到80后,心","images":[{"img":"https://static.tigerbbs.com/200786f004eebbcb102191a1173bc5b9","width":"452","height":"447"},{"img":"https://static.tigerbbs.com/4c12a3fac858cb634288a6606f70643c","width":"623","height":"622"},{"img":"https://static.tigerbbs.com/2adbfc3023d585b840c6fc536c2e877f","width":"491","height":"405"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":9,"commentSize":3,"repostSize":4,"link":"https://laohu8.com/post/338904251","isVote":1,"tweetType":1,"viewCount":11510,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":3,"langContent":"CN","totalScore":0},{"id":931620354,"gmtCreate":1570726887678,"gmtModify":1704721249362,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SGMO\">$Sangamo BioSciences(SGMO)$</a> 这货最近持续下跌,投资人不看好","listText":"<a href=\"https://laohu8.com/S/SGMO\">$Sangamo BioSciences(SGMO)$</a> 这货最近持续下跌,投资人不看好","text":"$Sangamo BioSciences(SGMO)$ 这货最近持续下跌,投资人不看好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/931620354","isVote":1,"tweetType":1,"viewCount":2662,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":389804,"gmtCreate":1548703039296,"gmtModify":1704788178764,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"htmlText":"$Sangamo BioSciences(SGMO)$估计二月份的报告会出些好结果,估计能涨涨","listText":"$Sangamo BioSciences(SGMO)$估计二月份的报告会出些好结果,估计能涨涨","text":"$Sangamo BioSciences(SGMO)$估计二月份的报告会出些好结果,估计能涨涨","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/389804","isVote":1,"tweetType":1,"viewCount":2321,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":220119,"gmtCreate":1531765177374,"gmtModify":1704896927772,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"htmlText":"$CRISPR Therapeutics AG(CRSP)$ crispr遭遇巨大挑战,短期内看空","listText":"$CRISPR Therapeutics AG(CRSP)$ crispr遭遇巨大挑战,短期内看空","text":"$CRISPR Therapeutics AG(CRSP)$ crispr遭遇巨大挑战,短期内看空","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/220119","isVote":1,"tweetType":1,"viewCount":2475,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":210916,"gmtCreate":1530211768262,"gmtModify":1704895801785,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"htmlText":"最近老虎行情刷新特别慢,个股新闻推送还停留在五月份。是我系统的问题吗?大家最近体验如何?","listText":"最近老虎行情刷新特别慢,个股新闻推送还停留在五月份。是我系统的问题吗?大家最近体验如何?","text":"最近老虎行情刷新特别慢,个股新闻推送还停留在五月份。是我系统的问题吗?大家最近体验如何?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/210916","isVote":1,"tweetType":1,"viewCount":1607,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":176442,"gmtCreate":1523304965538,"gmtModify":1704891443517,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"htmlText":"分析的好","listText":"分析的好","text":"分析的好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/176442","repostId":"176100","repostType":1,"repost":{"id":176100,"gmtCreate":1523202017157,"gmtModify":1704891402100,"author":{"id":"3484536045691836","authorId":"3484536045691836","name":"科迪勒拉","avatar":"https://static.tigerbbs.com/856f04bd0b055f6769e058b1751b7600","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3484536045691836","authorIdStr":"3484536045691836"},"themes":[],"title":"CNAT: 道阻且长 行则将至","htmlText":"$Conatus Pharmaceuticals Inc.(CNAT)$ 投资中真正需要的是思考而不是参考。 ----芒格 日前,CNAT公布了POLT-HCV-SVR关键的2b临床研究数据。客观地说,我们此前从未见过如此“好坏不清“”的数据。F2-F5组的数据已显示了emricasan抗纤维化的强大疗效,这足以让股价直上青云。谁能想到F6分组的3个安慰剂患者却以100:0的比分战胜了治疗组,此离群值直接拉低了全体治疗组的成绩,导致emricasan在此项试验中未达第一端点。反馈到市场上,其股价不涨反跌也就顺理成章了。 巴菲特和达里奥告诫我们: During times of volatility, it's best to stay calm and stick to the basics. 我们期望尽早见到公司进一步的评估结果及合作伙伴诺华的意见。以下分析文字编译自SA。 摘要: CNAT因2期数据下跌,但是阳性的分组数据分析将使该项临床试验继续 。 没有F6组中对安慰剂反应的3例异常情况,整个试验将会达到该项研究的首要端点。 F3-F5组纤维化试验数据对比强烈,emricasan 治疗组取得了95%的反应,而安慰剂组的反映比例为58.3%。 另一个催化剂事件,即肝硬化伴随门静脉高压的NASH患者身上进行的ENCORE-PH 2b试验预计在今年下半年公布数据。 财务状况良好,因CANT有足够的现金储备可坚持到2019年末,这意味着没有短期股权稀释风险。 日前,CNAT公布了POLT-HCV-SVR2b的临床研究结果。在仔细分析这些数据后,我必须说的是它们在药效方面属于中性,中性的意思是它们既非彻底的失败亦非巨大的成功。我要说的是,根据现有的结果分析,CNAT有能力将F3与F5之间纤维化分组病患人群的试验推进到3期。这是第一次有一款药物在此病患人群中显示了抗纤维化疗效。因","listText":"$Conatus Pharmaceuticals Inc.(CNAT)$ 投资中真正需要的是思考而不是参考。 ----芒格 日前,CNAT公布了POLT-HCV-SVR关键的2b临床研究数据。客观地说,我们此前从未见过如此“好坏不清“”的数据。F2-F5组的数据已显示了emricasan抗纤维化的强大疗效,这足以让股价直上青云。谁能想到F6分组的3个安慰剂患者却以100:0的比分战胜了治疗组,此离群值直接拉低了全体治疗组的成绩,导致emricasan在此项试验中未达第一端点。反馈到市场上,其股价不涨反跌也就顺理成章了。 巴菲特和达里奥告诫我们: During times of volatility, it's best to stay calm and stick to the basics. 我们期望尽早见到公司进一步的评估结果及合作伙伴诺华的意见。以下分析文字编译自SA。 摘要: CNAT因2期数据下跌,但是阳性的分组数据分析将使该项临床试验继续 。 没有F6组中对安慰剂反应的3例异常情况,整个试验将会达到该项研究的首要端点。 F3-F5组纤维化试验数据对比强烈,emricasan 治疗组取得了95%的反应,而安慰剂组的反映比例为58.3%。 另一个催化剂事件,即肝硬化伴随门静脉高压的NASH患者身上进行的ENCORE-PH 2b试验预计在今年下半年公布数据。 财务状况良好,因CANT有足够的现金储备可坚持到2019年末,这意味着没有短期股权稀释风险。 日前,CNAT公布了POLT-HCV-SVR2b的临床研究结果。在仔细分析这些数据后,我必须说的是它们在药效方面属于中性,中性的意思是它们既非彻底的失败亦非巨大的成功。我要说的是,根据现有的结果分析,CNAT有能力将F3与F5之间纤维化分组病患人群的试验推进到3期。这是第一次有一款药物在此病患人群中显示了抗纤维化疗效。因","text":"$Conatus Pharmaceuticals Inc.(CNAT)$ 投资中真正需要的是思考而不是参考。 ----芒格 日前,CNAT公布了POLT-HCV-SVR关键的2b临床研究数据。客观地说,我们此前从未见过如此“好坏不清“”的数据。F2-F5组的数据已显示了emricasan抗纤维化的强大疗效,这足以让股价直上青云。谁能想到F6分组的3个安慰剂患者却以100:0的比分战胜了治疗组,此离群值直接拉低了全体治疗组的成绩,导致emricasan在此项试验中未达第一端点。反馈到市场上,其股价不涨反跌也就顺理成章了。 巴菲特和达里奥告诫我们: During times of volatility, it's best to stay calm and stick to the basics. 我们期望尽早见到公司进一步的评估结果及合作伙伴诺华的意见。以下分析文字编译自SA。 摘要: CNAT因2期数据下跌,但是阳性的分组数据分析将使该项临床试验继续 。 没有F6组中对安慰剂反应的3例异常情况,整个试验将会达到该项研究的首要端点。 F3-F5组纤维化试验数据对比强烈,emricasan 治疗组取得了95%的反应,而安慰剂组的反映比例为58.3%。 另一个催化剂事件,即肝硬化伴随门静脉高压的NASH患者身上进行的ENCORE-PH 2b试验预计在今年下半年公布数据。 财务状况良好,因CANT有足够的现金储备可坚持到2019年末,这意味着没有短期股权稀释风险。 日前,CNAT公布了POLT-HCV-SVR2b的临床研究结果。在仔细分析这些数据后,我必须说的是它们在药效方面属于中性,中性的意思是它们既非彻底的失败亦非巨大的成功。我要说的是,根据现有的结果分析,CNAT有能力将F3与F5之间纤维化分组病患人群的试验推进到3期。这是第一次有一款药物在此病患人群中显示了抗纤维化疗效。因","images":[{"img":"https://static.laohu8.com/346fb885397b85b6724c7bd8e637f273"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/176100","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":2166,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":160642,"gmtCreate":1518802087118,"gmtModify":1704889453203,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"htmlText":"$Eyenovia Inc.(EYEN)$这股成交量可真惨淡","listText":"$Eyenovia Inc.(EYEN)$这股成交量可真惨淡","text":"$Eyenovia Inc.(EYEN)$这股成交量可真惨淡","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/160642","isVote":1,"tweetType":1,"viewCount":3810,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":122471,"gmtCreate":1511808592661,"gmtModify":1704884670132,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"title":"这股最近强势反弹,看来有翻身的机会了","htmlText":"$Northwest Biotherapeutics(NWBO)$这股最近强势反弹,看来有翻身的机会了","listText":"$Northwest Biotherapeutics(NWBO)$这股最近强势反弹,看来有翻身的机会了","text":"$Northwest Biotherapeutics(NWBO)$这股最近强势反弹,看来有翻身的机会了","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/122471","isVote":1,"tweetType":1,"viewCount":3052,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":99141,"gmtCreate":1506616799422,"gmtModify":1704881726365,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"title":"看好产品线,应该会涨起来","htmlText":"$Deciphera Pharmaceuticals Inc.(DCPH)$新股发行第一帖,果断入手1000股,早晚能涨起来","listText":"$Deciphera Pharmaceuticals Inc.(DCPH)$新股发行第一帖,果断入手1000股,早晚能涨起来","text":"$Deciphera Pharmaceuticals Inc.(DCPH)$新股发行第一帖,果断入手1000股,早晚能涨起来","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":1,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/99141","isVote":1,"tweetType":1,"viewCount":3059,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":88350,"gmtCreate":1503491946927,"gmtModify":1704880520906,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"title":"有收购传闻,要上吗?","htmlText":"$Paratek Pharmaceuticals Inc.(PRTK)$盘前暴涨","listText":"$Paratek Pharmaceuticals Inc.(PRTK)$盘前暴涨","text":"$Paratek Pharmaceuticals Inc.(PRTK)$盘前暴涨","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/88350","isVote":1,"tweetType":1,"viewCount":3138,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":78976,"gmtCreate":1501276439067,"gmtModify":1704879382175,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"htmlText":"$德纳维制药(DVAX)$乙肝疫苗终于被认可了,投票11:1 推荐,果断买入,15.7-16.0入手,下周开盘还会继续大涨","listText":"$德纳维制药(DVAX)$乙肝疫苗终于被认可了,投票11:1 推荐,果断买入,15.7-16.0入手,下周开盘还会继续大涨","text":"$德纳维制药(DVAX)$乙肝疫苗终于被认可了,投票11:1 推荐,果断买入,15.7-16.0入手,下周开盘还会继续大涨","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/78976","isVote":1,"tweetType":1,"viewCount":1659,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"302257975270708","authorId":"302257975270708","name":"空空得只隼","avatar":"https://static.tigerbbs.com/8981b04da1c29d39ebbc436041bb1c08","crmLevel":7,"crmLevelSwitch":0,"idStr":"302257975270708","authorIdStr":"302257975270708"},"content":"不理解,乙肝疫苗不是什么新药物吧,在中国随便可以打这个疫苗","text":"不理解,乙肝疫苗不是什么新药物吧,在中国随便可以打这个疫苗","html":"不理解,乙肝疫苗不是什么新药物吧,在中国随便可以打这个疫苗"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":77877,"gmtCreate":1501102121654,"gmtModify":1704879242702,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"htmlText":"$Intellipharmaceutics Internation(IPCI)$FDA拒了","listText":"$Intellipharmaceutics Internation(IPCI)$FDA拒了","text":"$Intellipharmaceutics Internation(IPCI)$FDA拒了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/77877","isVote":1,"tweetType":1,"viewCount":1963,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":76098,"gmtCreate":1500580287658,"gmtModify":1704879036195,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"htmlText":"$Kala Pharmaceuticals Inc.(KALA)$继续打新股, 好的公司打新还是相当安全的","listText":"$Kala Pharmaceuticals Inc.(KALA)$继续打新股, 好的公司打新还是相当安全的","text":"$Kala Pharmaceuticals Inc.(KALA)$继续打新股, 好的公司打新还是相当安全的","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/76098","isVote":1,"tweetType":1,"viewCount":3663,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3463690403474527","authorId":"3463690403474527","name":"_HR_","avatar":"https://static.laohu8.com/dd9ec9fefb0df3ebcdfeb2d3a050b8b3","crmLevel":1,"crmLevelSwitch":0,"idStr":"3463690403474527","authorIdStr":"3463690403474527"},"content":"周一还适合入吗?","text":"周一还适合入吗?","html":"周一还适合入吗?"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":74381,"gmtCreate":1500027227481,"gmtModify":1704878817398,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"htmlText":"$Portola Pharmaceuticals Inc.(PTLA)$这股自从拿到批件暴涨后还在慢慢涨,长期看好啊","listText":"$Portola Pharmaceuticals Inc.(PTLA)$这股自从拿到批件暴涨后还在慢慢涨,长期看好啊","text":"$Portola Pharmaceuticals Inc.(PTLA)$这股自从拿到批件暴涨后还在慢慢涨,长期看好啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/74381","isVote":1,"tweetType":1,"viewCount":2250,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":72964,"gmtCreate":1499449538279,"gmtModify":1704878638524,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"htmlText":"$Pieris Pharmaceuticals, Inc.(PIRS)$ 趋势不错,长期看好","listText":"$Pieris Pharmaceuticals, Inc.(PIRS)$ 趋势不错,长期看好","text":"$Pieris Pharmaceuticals, Inc.(PIRS)$ 趋势不错,长期看好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/72964","isVote":1,"tweetType":1,"viewCount":1745,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":697545111,"gmtCreate":1642543262290,"gmtModify":1642598804002,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a>做个实验,看看自己能不能发帖?手机端总是显示中国人要实名认证,课我在海外没有国内手机","listText":"<a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a>做个实验,看看自己能不能发帖?手机端总是显示中国人要实名认证,课我在海外没有国内手机","text":"$特斯拉(TSLA)$做个实验,看看自己能不能发帖?手机端总是显示中国人要实名认证,课我在海外没有国内手机","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":217,"commentSize":49,"repostSize":28,"link":"https://laohu8.com/post/697545111","isVote":1,"tweetType":1,"viewCount":9910,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"275819275022896","authorId":"275819275022896","name":"约翰","avatar":"https://static.tigerbbs.com/ad1bbc78ee49142cbe14dec72f0436a6","crmLevel":1,"crmLevelSwitch":0,"idStr":"275819275022896","authorIdStr":"275819275022896"},"content":"我带着中国的华为和中国电信芯片和号码,在加拿大用苹果手机下载老虎证券app, 登陆时用中国号码,密码自己设定,第一次好像要验证码。","text":"我带着中国的华为和中国电信芯片和号码,在加拿大用苹果手机下载老虎证券app, 登陆时用中国号码,密码自己设定,第一次好像要验证码。","html":"我带着中国的华为和中国电信芯片和号码,在加拿大用苹果手机下载老虎证券app, 登陆时用中国号码,密码自己设定,第一次好像要验证码。"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697545586,"gmtCreate":1642543473616,"gmtModify":1642543473616,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RIVN\">$Rivian Automotive, Inc.(RIVN)$</a>上周买了82的put,1.21到期,希望它继续跌,弥补我在 $Tesla$ call 上的损失","listText":"<a href=\"https://laohu8.com/S/RIVN\">$Rivian Automotive, Inc.(RIVN)$</a>上周买了82的put,1.21到期,希望它继续跌,弥补我在 $Tesla$ call 上的损失","text":"$Rivian Automotive, Inc.(RIVN)$上周买了82的put,1.21到期,希望它继续跌,弥补我在 $Tesla$ call 上的损失","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":72,"commentSize":12,"repostSize":1,"link":"https://laohu8.com/post/697545586","isVote":1,"tweetType":1,"viewCount":1726,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":338904251,"gmtCreate":1609797702373,"gmtModify":1715012530169,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"title":"2020 美股疫苗股交易总结","htmlText":"2020年无疑是整个人类社会的一个大灾难,但因为疫情造成的股市震荡真是一个千载难逢的挣钱机会,如果抓住机会,是可以大挣一笔的。可惜本人水平有限,没能挣到太多,但确实也学到了很多心得,一些血的教训,希望对自己将来的投资有帮助。本文总结自己2020年疫苗股的交易过程。<a target=\"_blank\" href=\"https://laohu8.com/S/NNVC\">$NanoViricides Inc.(NNVC)$</a> : 疫情在武汉一月份爆发,美股马上跟风,相关概念股水涨船高。首先进入视线的是一只垃圾股,NNVC,几个印度人搞的一个空壳公司,靠蹭热点,一个概念炒了N多年,实际上药物研发没有任何进展。因为CEO在采访时大放厥词,他们的产品有可能对病毒有效,股价直接暴涨。在研究明白这家公司的本质后,果断做空,8.5 和9.5元两处卖空股票,坚信这只垃圾股早晚会跌回5元以下(备注2020.12.31 收盘价2.87)。可是美股太疯狂了,风口来了,猪都会飞,这只垃圾股最高窜到19.2,弄得我心惊胆战。最后在8 和7.5 位置平了空仓,小获利了结。心得:虽然坚信长期方向,但做空压力太大,心态不够坚定,拿不住。<a target=\"_blank\" href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a> :2019年因为工作原因就了解了mRNA疫苗,非常看好mRNA疫苗的方向,ModernRNA和BioNTech公司一直在我观察列表里,可惜没有入手买。2020.6MRNA临床一期结果出来后,股价暴涨到87 后慢慢下跌,根据我对他们技术和数据的分析,认为后续2/3期希望很大,于是在6月份回调后60左右建仓。很快,7月底受临床2期好结果刺激,又一**涨。这时候我的心态问题又犯病了,第一天暴涨到80后,心","listText":"2020年无疑是整个人类社会的一个大灾难,但因为疫情造成的股市震荡真是一个千载难逢的挣钱机会,如果抓住机会,是可以大挣一笔的。可惜本人水平有限,没能挣到太多,但确实也学到了很多心得,一些血的教训,希望对自己将来的投资有帮助。本文总结自己2020年疫苗股的交易过程。<a target=\"_blank\" href=\"https://laohu8.com/S/NNVC\">$NanoViricides Inc.(NNVC)$</a> : 疫情在武汉一月份爆发,美股马上跟风,相关概念股水涨船高。首先进入视线的是一只垃圾股,NNVC,几个印度人搞的一个空壳公司,靠蹭热点,一个概念炒了N多年,实际上药物研发没有任何进展。因为CEO在采访时大放厥词,他们的产品有可能对病毒有效,股价直接暴涨。在研究明白这家公司的本质后,果断做空,8.5 和9.5元两处卖空股票,坚信这只垃圾股早晚会跌回5元以下(备注2020.12.31 收盘价2.87)。可是美股太疯狂了,风口来了,猪都会飞,这只垃圾股最高窜到19.2,弄得我心惊胆战。最后在8 和7.5 位置平了空仓,小获利了结。心得:虽然坚信长期方向,但做空压力太大,心态不够坚定,拿不住。<a target=\"_blank\" href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a> :2019年因为工作原因就了解了mRNA疫苗,非常看好mRNA疫苗的方向,ModernRNA和BioNTech公司一直在我观察列表里,可惜没有入手买。2020.6MRNA临床一期结果出来后,股价暴涨到87 后慢慢下跌,根据我对他们技术和数据的分析,认为后续2/3期希望很大,于是在6月份回调后60左右建仓。很快,7月底受临床2期好结果刺激,又一**涨。这时候我的心态问题又犯病了,第一天暴涨到80后,心","text":"2020年无疑是整个人类社会的一个大灾难,但因为疫情造成的股市震荡真是一个千载难逢的挣钱机会,如果抓住机会,是可以大挣一笔的。可惜本人水平有限,没能挣到太多,但确实也学到了很多心得,一些血的教训,希望对自己将来的投资有帮助。本文总结自己2020年疫苗股的交易过程。$NanoViricides Inc.(NNVC)$ : 疫情在武汉一月份爆发,美股马上跟风,相关概念股水涨船高。首先进入视线的是一只垃圾股,NNVC,几个印度人搞的一个空壳公司,靠蹭热点,一个概念炒了N多年,实际上药物研发没有任何进展。因为CEO在采访时大放厥词,他们的产品有可能对病毒有效,股价直接暴涨。在研究明白这家公司的本质后,果断做空,8.5 和9.5元两处卖空股票,坚信这只垃圾股早晚会跌回5元以下(备注2020.12.31 收盘价2.87)。可是美股太疯狂了,风口来了,猪都会飞,这只垃圾股最高窜到19.2,弄得我心惊胆战。最后在8 和7.5 位置平了空仓,小获利了结。心得:虽然坚信长期方向,但做空压力太大,心态不够坚定,拿不住。$Moderna, Inc.(MRNA)$ :2019年因为工作原因就了解了mRNA疫苗,非常看好mRNA疫苗的方向,ModernRNA和BioNTech公司一直在我观察列表里,可惜没有入手买。2020.6MRNA临床一期结果出来后,股价暴涨到87 后慢慢下跌,根据我对他们技术和数据的分析,认为后续2/3期希望很大,于是在6月份回调后60左右建仓。很快,7月底受临床2期好结果刺激,又一**涨。这时候我的心态问题又犯病了,第一天暴涨到80后,心","images":[{"img":"https://static.tigerbbs.com/200786f004eebbcb102191a1173bc5b9","width":"452","height":"447"},{"img":"https://static.tigerbbs.com/4c12a3fac858cb634288a6606f70643c","width":"623","height":"622"},{"img":"https://static.tigerbbs.com/2adbfc3023d585b840c6fc536c2e877f","width":"491","height":"405"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":9,"commentSize":3,"repostSize":4,"link":"https://laohu8.com/post/338904251","isVote":1,"tweetType":1,"viewCount":11510,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":3,"langContent":"CN","totalScore":0},{"id":78976,"gmtCreate":1501276439067,"gmtModify":1704879382175,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"htmlText":"$德纳维制药(DVAX)$乙肝疫苗终于被认可了,投票11:1 推荐,果断买入,15.7-16.0入手,下周开盘还会继续大涨","listText":"$德纳维制药(DVAX)$乙肝疫苗终于被认可了,投票11:1 推荐,果断买入,15.7-16.0入手,下周开盘还会继续大涨","text":"$德纳维制药(DVAX)$乙肝疫苗终于被认可了,投票11:1 推荐,果断买入,15.7-16.0入手,下周开盘还会继续大涨","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/78976","isVote":1,"tweetType":1,"viewCount":1659,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"302257975270708","authorId":"302257975270708","name":"空空得只隼","avatar":"https://static.tigerbbs.com/8981b04da1c29d39ebbc436041bb1c08","crmLevel":7,"crmLevelSwitch":0,"idStr":"302257975270708","authorIdStr":"302257975270708"},"content":"不理解,乙肝疫苗不是什么新药物吧,在中国随便可以打这个疫苗","text":"不理解,乙肝疫苗不是什么新药物吧,在中国随便可以打这个疫苗","html":"不理解,乙肝疫苗不是什么新药物吧,在中国随便可以打这个疫苗"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":99141,"gmtCreate":1506616799422,"gmtModify":1704881726365,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"title":"看好产品线,应该会涨起来","htmlText":"$Deciphera Pharmaceuticals Inc.(DCPH)$新股发行第一帖,果断入手1000股,早晚能涨起来","listText":"$Deciphera Pharmaceuticals Inc.(DCPH)$新股发行第一帖,果断入手1000股,早晚能涨起来","text":"$Deciphera Pharmaceuticals Inc.(DCPH)$新股发行第一帖,果断入手1000股,早晚能涨起来","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":1,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/99141","isVote":1,"tweetType":1,"viewCount":3059,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":76098,"gmtCreate":1500580287658,"gmtModify":1704879036195,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"htmlText":"$Kala Pharmaceuticals Inc.(KALA)$继续打新股, 好的公司打新还是相当安全的","listText":"$Kala Pharmaceuticals Inc.(KALA)$继续打新股, 好的公司打新还是相当安全的","text":"$Kala Pharmaceuticals Inc.(KALA)$继续打新股, 好的公司打新还是相当安全的","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/76098","isVote":1,"tweetType":1,"viewCount":3663,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3463690403474527","authorId":"3463690403474527","name":"_HR_","avatar":"https://static.laohu8.com/dd9ec9fefb0df3ebcdfeb2d3a050b8b3","crmLevel":1,"crmLevelSwitch":0,"idStr":"3463690403474527","authorIdStr":"3463690403474527"},"content":"周一还适合入吗?","text":"周一还适合入吗?","html":"周一还适合入吗?"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":931620354,"gmtCreate":1570726887678,"gmtModify":1704721249362,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SGMO\">$Sangamo BioSciences(SGMO)$</a> 这货最近持续下跌,投资人不看好","listText":"<a href=\"https://laohu8.com/S/SGMO\">$Sangamo BioSciences(SGMO)$</a> 这货最近持续下跌,投资人不看好","text":"$Sangamo BioSciences(SGMO)$ 这货最近持续下跌,投资人不看好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/931620354","isVote":1,"tweetType":1,"viewCount":2662,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":72964,"gmtCreate":1499449538279,"gmtModify":1704878638524,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"htmlText":"$Pieris Pharmaceuticals, Inc.(PIRS)$ 趋势不错,长期看好","listText":"$Pieris Pharmaceuticals, Inc.(PIRS)$ 趋势不错,长期看好","text":"$Pieris Pharmaceuticals, Inc.(PIRS)$ 趋势不错,长期看好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/72964","isVote":1,"tweetType":1,"viewCount":1745,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":389804,"gmtCreate":1548703039296,"gmtModify":1704788178764,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"htmlText":"$Sangamo BioSciences(SGMO)$估计二月份的报告会出些好结果,估计能涨涨","listText":"$Sangamo BioSciences(SGMO)$估计二月份的报告会出些好结果,估计能涨涨","text":"$Sangamo BioSciences(SGMO)$估计二月份的报告会出些好结果,估计能涨涨","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/389804","isVote":1,"tweetType":1,"viewCount":2321,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":160642,"gmtCreate":1518802087118,"gmtModify":1704889453203,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"htmlText":"$Eyenovia Inc.(EYEN)$这股成交量可真惨淡","listText":"$Eyenovia Inc.(EYEN)$这股成交量可真惨淡","text":"$Eyenovia Inc.(EYEN)$这股成交量可真惨淡","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/160642","isVote":1,"tweetType":1,"viewCount":3810,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":88350,"gmtCreate":1503491946927,"gmtModify":1704880520906,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"title":"有收购传闻,要上吗?","htmlText":"$Paratek Pharmaceuticals Inc.(PRTK)$盘前暴涨","listText":"$Paratek Pharmaceuticals Inc.(PRTK)$盘前暴涨","text":"$Paratek Pharmaceuticals Inc.(PRTK)$盘前暴涨","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/88350","isVote":1,"tweetType":1,"viewCount":3138,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":77877,"gmtCreate":1501102121654,"gmtModify":1704879242702,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"htmlText":"$Intellipharmaceutics Internation(IPCI)$FDA拒了","listText":"$Intellipharmaceutics Internation(IPCI)$FDA拒了","text":"$Intellipharmaceutics Internation(IPCI)$FDA拒了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/77877","isVote":1,"tweetType":1,"viewCount":1963,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":220119,"gmtCreate":1531765177374,"gmtModify":1704896927772,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"htmlText":"$CRISPR Therapeutics AG(CRSP)$ crispr遭遇巨大挑战,短期内看空","listText":"$CRISPR Therapeutics AG(CRSP)$ crispr遭遇巨大挑战,短期内看空","text":"$CRISPR Therapeutics AG(CRSP)$ crispr遭遇巨大挑战,短期内看空","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/220119","isVote":1,"tweetType":1,"viewCount":2475,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":106745387,"gmtCreate":1620156884249,"gmtModify":1620156884249,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AVIR\">$Atea Pharmaceuticals, Inc.(AVIR)$</a>Merck宣布免费授权给印度它的抗病毒药,对ATEA是一大利空。另外,好像流通股变多了很多。","listText":"<a href=\"https://laohu8.com/S/AVIR\">$Atea Pharmaceuticals, Inc.(AVIR)$</a>Merck宣布免费授权给印度它的抗病毒药,对ATEA是一大利空。另外,好像流通股变多了很多。","text":"$Atea Pharmaceuticals, Inc.(AVIR)$Merck宣布免费授权给印度它的抗病毒药,对ATEA是一大利空。另外,好像流通股变多了很多。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/106745387","isVote":1,"tweetType":1,"viewCount":2696,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":210916,"gmtCreate":1530211768262,"gmtModify":1704895801785,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"htmlText":"最近老虎行情刷新特别慢,个股新闻推送还停留在五月份。是我系统的问题吗?大家最近体验如何?","listText":"最近老虎行情刷新特别慢,个股新闻推送还停留在五月份。是我系统的问题吗?大家最近体验如何?","text":"最近老虎行情刷新特别慢,个股新闻推送还停留在五月份。是我系统的问题吗?大家最近体验如何?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/210916","isVote":1,"tweetType":1,"viewCount":1607,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":176442,"gmtCreate":1523304965538,"gmtModify":1704891443517,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"htmlText":"分析的好","listText":"分析的好","text":"分析的好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/176442","repostId":"176100","repostType":1,"repost":{"id":176100,"gmtCreate":1523202017157,"gmtModify":1704891402100,"author":{"id":"3484536045691836","authorId":"3484536045691836","name":"科迪勒拉","avatar":"https://static.tigerbbs.com/856f04bd0b055f6769e058b1751b7600","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3484536045691836","authorIdStr":"3484536045691836"},"themes":[],"title":"CNAT: 道阻且长 行则将至","htmlText":"$Conatus Pharmaceuticals Inc.(CNAT)$ 投资中真正需要的是思考而不是参考。 ----芒格 日前,CNAT公布了POLT-HCV-SVR关键的2b临床研究数据。客观地说,我们此前从未见过如此“好坏不清“”的数据。F2-F5组的数据已显示了emricasan抗纤维化的强大疗效,这足以让股价直上青云。谁能想到F6分组的3个安慰剂患者却以100:0的比分战胜了治疗组,此离群值直接拉低了全体治疗组的成绩,导致emricasan在此项试验中未达第一端点。反馈到市场上,其股价不涨反跌也就顺理成章了。 巴菲特和达里奥告诫我们: During times of volatility, it's best to stay calm and stick to the basics. 我们期望尽早见到公司进一步的评估结果及合作伙伴诺华的意见。以下分析文字编译自SA。 摘要: CNAT因2期数据下跌,但是阳性的分组数据分析将使该项临床试验继续 。 没有F6组中对安慰剂反应的3例异常情况,整个试验将会达到该项研究的首要端点。 F3-F5组纤维化试验数据对比强烈,emricasan 治疗组取得了95%的反应,而安慰剂组的反映比例为58.3%。 另一个催化剂事件,即肝硬化伴随门静脉高压的NASH患者身上进行的ENCORE-PH 2b试验预计在今年下半年公布数据。 财务状况良好,因CANT有足够的现金储备可坚持到2019年末,这意味着没有短期股权稀释风险。 日前,CNAT公布了POLT-HCV-SVR2b的临床研究结果。在仔细分析这些数据后,我必须说的是它们在药效方面属于中性,中性的意思是它们既非彻底的失败亦非巨大的成功。我要说的是,根据现有的结果分析,CNAT有能力将F3与F5之间纤维化分组病患人群的试验推进到3期。这是第一次有一款药物在此病患人群中显示了抗纤维化疗效。因","listText":"$Conatus Pharmaceuticals Inc.(CNAT)$ 投资中真正需要的是思考而不是参考。 ----芒格 日前,CNAT公布了POLT-HCV-SVR关键的2b临床研究数据。客观地说,我们此前从未见过如此“好坏不清“”的数据。F2-F5组的数据已显示了emricasan抗纤维化的强大疗效,这足以让股价直上青云。谁能想到F6分组的3个安慰剂患者却以100:0的比分战胜了治疗组,此离群值直接拉低了全体治疗组的成绩,导致emricasan在此项试验中未达第一端点。反馈到市场上,其股价不涨反跌也就顺理成章了。 巴菲特和达里奥告诫我们: During times of volatility, it's best to stay calm and stick to the basics. 我们期望尽早见到公司进一步的评估结果及合作伙伴诺华的意见。以下分析文字编译自SA。 摘要: CNAT因2期数据下跌,但是阳性的分组数据分析将使该项临床试验继续 。 没有F6组中对安慰剂反应的3例异常情况,整个试验将会达到该项研究的首要端点。 F3-F5组纤维化试验数据对比强烈,emricasan 治疗组取得了95%的反应,而安慰剂组的反映比例为58.3%。 另一个催化剂事件,即肝硬化伴随门静脉高压的NASH患者身上进行的ENCORE-PH 2b试验预计在今年下半年公布数据。 财务状况良好,因CANT有足够的现金储备可坚持到2019年末,这意味着没有短期股权稀释风险。 日前,CNAT公布了POLT-HCV-SVR2b的临床研究结果。在仔细分析这些数据后,我必须说的是它们在药效方面属于中性,中性的意思是它们既非彻底的失败亦非巨大的成功。我要说的是,根据现有的结果分析,CNAT有能力将F3与F5之间纤维化分组病患人群的试验推进到3期。这是第一次有一款药物在此病患人群中显示了抗纤维化疗效。因","text":"$Conatus Pharmaceuticals Inc.(CNAT)$ 投资中真正需要的是思考而不是参考。 ----芒格 日前,CNAT公布了POLT-HCV-SVR关键的2b临床研究数据。客观地说,我们此前从未见过如此“好坏不清“”的数据。F2-F5组的数据已显示了emricasan抗纤维化的强大疗效,这足以让股价直上青云。谁能想到F6分组的3个安慰剂患者却以100:0的比分战胜了治疗组,此离群值直接拉低了全体治疗组的成绩,导致emricasan在此项试验中未达第一端点。反馈到市场上,其股价不涨反跌也就顺理成章了。 巴菲特和达里奥告诫我们: During times of volatility, it's best to stay calm and stick to the basics. 我们期望尽早见到公司进一步的评估结果及合作伙伴诺华的意见。以下分析文字编译自SA。 摘要: CNAT因2期数据下跌,但是阳性的分组数据分析将使该项临床试验继续 。 没有F6组中对安慰剂反应的3例异常情况,整个试验将会达到该项研究的首要端点。 F3-F5组纤维化试验数据对比强烈,emricasan 治疗组取得了95%的反应,而安慰剂组的反映比例为58.3%。 另一个催化剂事件,即肝硬化伴随门静脉高压的NASH患者身上进行的ENCORE-PH 2b试验预计在今年下半年公布数据。 财务状况良好,因CANT有足够的现金储备可坚持到2019年末,这意味着没有短期股权稀释风险。 日前,CNAT公布了POLT-HCV-SVR2b的临床研究结果。在仔细分析这些数据后,我必须说的是它们在药效方面属于中性,中性的意思是它们既非彻底的失败亦非巨大的成功。我要说的是,根据现有的结果分析,CNAT有能力将F3与F5之间纤维化分组病患人群的试验推进到3期。这是第一次有一款药物在此病患人群中显示了抗纤维化疗效。因","images":[{"img":"https://static.laohu8.com/346fb885397b85b6724c7bd8e637f273"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/176100","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":2166,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":122471,"gmtCreate":1511808592661,"gmtModify":1704884670132,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"title":"这股最近强势反弹,看来有翻身的机会了","htmlText":"$Northwest Biotherapeutics(NWBO)$这股最近强势反弹,看来有翻身的机会了","listText":"$Northwest Biotherapeutics(NWBO)$这股最近强势反弹,看来有翻身的机会了","text":"$Northwest Biotherapeutics(NWBO)$这股最近强势反弹,看来有翻身的机会了","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/122471","isVote":1,"tweetType":1,"viewCount":3052,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":74381,"gmtCreate":1500027227481,"gmtModify":1704878817398,"author":{"id":"3461771638976755","authorId":"3461771638976755","name":"Pharmyang","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3461771638976755","authorIdStr":"3461771638976755"},"themes":[],"htmlText":"$Portola Pharmaceuticals Inc.(PTLA)$这股自从拿到批件暴涨后还在慢慢涨,长期看好啊","listText":"$Portola Pharmaceuticals Inc.(PTLA)$这股自从拿到批件暴涨后还在慢慢涨,长期看好啊","text":"$Portola Pharmaceuticals Inc.(PTLA)$这股自从拿到批件暴涨后还在慢慢涨,长期看好啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/74381","isVote":1,"tweetType":1,"viewCount":2250,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}